Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use
Placebo-Controlled Evaluation of the Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use
Sponsor: Boston University Charles River Campus
Terminated
The investigators failed to recruit participants as originally projected.
Other terminated trials from Boston University Charles River Campus
- Anxiety · Phase NA · Jul 2022
- Smoking Cessation · Phase NA · Aug 2021
- Anxiety Disorders · Phase NA · Mar 2017
See all terminations from Boston University Charles River Campus
Other Substance-Related Disorders trials with similar outcome
A PHASE2 clinical study on Substance-Related Disorders, this trial is terminated or withdrawn. The trial is conducted by Boston University Charles River Campus and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 3 earlier versions
-
Jul 2017 — Jun 2018 [monthly]
Terminated PHASE2
Status: Completed → Terminated
-
Jun 2017 — Jul 2017 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2017 [monthly]
Completed PHASE2
First recorded
Feb 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston University Charles River Campus
- Massachusetts General Hospital
- National Institute on Drug Abuse (NIDA)
For direct contact, visit the study record on ClinicalTrials.gov .